Africa within the global pharmaceutical market In 2016, global pharmaceutical revenues totalled over US$ 1,105 billion and are forecast to reach US$ 1,400 billion by 2021, especially thanks to the growth in “pharmerging” countries1. *\"��b�-x�S��C334C����v�|CCo�_�.��2ھ|��V�_g��{�V�4���9]�{w�;���gJa# M҉���ek�vb��gbJa�*��������bg2{��4����2�$IV��YV�����):�`.�(��g���Q�Hvշ�*�c
�N�O�8*��^�\upY�W�A�)�E�>9���`������*Å�'[�:�{DT����,���)�CN���m��vP��h��s�r����݄ Based in Geneva, IFPMA has official relations with the United Nations and contributes industry expertise to help the global health community find solutions that improve global health. Its core problem is lack of productivity in the lab. Sponsored by: AMRI, Thermo Fisher Scientific, and West Pharmaceutical Services, Inc. DCAT Week’s Pharma Industry Outlook program is the most sought-after resource for the latest market data and analysis of pharmaceutical industry performance. N'��)�].�u�J�r� 0000004359 00000 n
Yet the biopharmaceutical sector (Pharma) will find it hard to capitalise on these opportunities unless it can change the way in which it functions. 0000079168 00000 n
0000005155 00000 n
xref
n�3ܣ�k�Gݯz=��[=��=�B�0FX'�+������t���G�,�}���/���Hh8�m�W�2p[����AiA��N�#8$X�?�A�KHI�{!7�. Top 10 pharmaceutical markets by value (USD) 2011-2017. Pharmaceutical sciences in 2020 Daan Crommelin, Pieter Stolk, Luc Besançon, Vinod Shah, Kamal Midha and Hubert Leufkens Letter Bench: Boex 3D Creative Solutions. 0000001852 00000 n
I hope you find this report informative in its future-forward look at GBS and where the industry stands the most to gain in the years ahead. :�pى�~�G�w Ot"�O�"��qf)l7>T��qt�{�5��.�]������#{I-������iCހy���0 -0JB��L̝d�Dq�"�����C� y^����n|��'}d���.r�&�`?�A�)|���`�Ǖ;�� ��P
0000079972 00000 n
0000076363 00000 n
The African Continent only accounts for 0.7% of this Understanding the long-term future is vital in ensuring that strategies are �B��)t xڼT�O[U?�����Lޫ:u��(�S��6�@�ڥ26['Lխ8����_PLe{�f��!�u,Dt���̌��2��,�܌F6�?�L���~�?���w�=�s?�sλ� �k= ��C@�`�;��cDg"t��a�\*��k0>���v�N�h{��閹o����*Ra�����d$�2%�}��������㩼� O�iK�q��������sU��w���#+ݍ.o���/�^��=�����d#�۹��kw���ܰ�'�\]�c׃�-�}����6�
��J4,���L�y#:�
z'��q�S�s뗯�����o���95�$`���:#F�F��Ǜ���lP�,��������k���/!go�'�w,��4�=W�$oQ]O7`��ߊ
��v*"��y��GBi�i����]SH�f)�/�Kc�U���TYU���c/��9M�������>���j�������w����"C�5�'��Qq�-���^a��z�`Zi����I�L����X9B��f~�=A�6���K��������颱�����f* �;����.w���. The novel coronavirus disease 2019 (COVID-19) was characterized as a global pandemic by the WHO on March 11th, 2020. 2y�.-;!���K�Z� ���^�i�"L��0���-��
@8(��r�;q��7�L��y��&�Q��q�4�j���|�9�� The pharmaceutical commercial model in 2020 Local is important but with a shift from volume to value 28 Wearables and mHealth applications in 2020 Measuring quality of life not just clinical indicators 12 The pharmaceutical enterprise configuration – the back office in 2020 Single, global organisation responsible for insight enablement 32 0000079660 00000 n
218 0 obj<>stream
While growth in developed markets will slow down, emerging markets will become increasingly important in the coming decade. Market Overview. U. S. (United States) pharmaceutical market is the largest pharmaceuticals market in the world and accounted for more than 40% global pharmaceuticals sales in 2017. For example, the IMS Institute for Healthcare Informatics anticipates international medication consumption increasing to 4.5 billion standard units (standard unit for volume of pharmaceutical formulations) by 2020. But ignoring long-term trends—demographic, economic, corporate—is an even less attractive option. �B��)�g�>��p��,��J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¯�+�J�¬t*�F��it�F��it�F��it�f�3�L��it�F�tF�N���48������������ �?������� �?������� UL�����dƘ�3c-�0c-�N���2~ے���[K�g�5���-���Ř-�j�����Ԡ��+X�o=�q�;�w�=O�_�QS�v�~�Tk��>Y��� ��wi�� ]�g�
Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage - In the Asia Pacific region growth forecasts are provided for … endstream
endobj
203 0 obj<>
endobj
204 0 obj<>
endobj
205 0 obj<>stream
Figure 59 Global Inventory by Product.....136 Figure 60 Average Inventory by Top Brands ... illustrate supply chain excellence with respect to the current pharmaceutical industry. THE PHARMACEUTICAL MARKET • The global pharmaceutical market will reach nearly USD 1,430 billion by 2020. 0000003216 00000 n
Several external factors have arguably exacerbated the industry’s Market shares for medicines launched in the previous 5 years. Global Use of Medicines in 2020. Chris Stirling Chair, Global Life Sciences Partner, KPMG in the UK christopher.stirling@kpmg.co.uk Introduction 1 … 2020—but lag overall healthcare expenditure as profi t-ability declines in aggregate worldwide4 (see Figure 1). 0000004268 00000 n
0000002390 00000 n
Projections indicate positive development over the next few years. - In the Asia Pacific region growth forecasts are provided for Australia, China, India, Japan and South Korea. Report: Global life sciences outlook 2020 March 2020 r. Gene therapy, wearables, telemedicine, and the identification and development of new drugs are just some of the trends that will dominate the pharmaceutical market in the years to come. 0000005023 00000 n
§ The pharmaceutical industry is likely to triple in size in by 2060 on an inflation-adjusted basis § The pharmaceutical industry is around 30% larger than previously thought and is one of top five in the global economy § Major innovations will continue to drive the size and growth of the industry … pharmaceutical industry can improve its global market share to ~7.0% by 2030 from current market share of 3.6%17 by value. jhealeco.2016.01.012 [Accessed 28 January 2020]. ndaconnect@nishithdesai.com ©Nishith Desai Associates 2019 February 2019 The Indian Pharmaceutical Industry Business, Legal & Tax Perspective DMS Code - 478882 Foresight 2020 Economic, industry and corporate trends In an age of uncertainty, peering 15 years into the future may seem like hubris. 0000000756 00000 n
The Indian Pharmaceutical Industry is the 3rd largest pharmaceutical market in terms of volume and 10th largest in terms of value, contributing towards 10% of global production. Mr Krugmann, how will the global pharmaceutical market develop unitl 2020? �V��)g�B�0�i�W��8#�8wթ��8_�٥ʨQ����Q�j@�&�A)/��g�>'K�� �t�;\��
ӥ$պF�ZUn����(4T�%)뫔�0C&�����Z��i���8��bx��E���B�;�����P���ӓ̹�A�om?�W= �ꇆ��n���Q�t�}MA�0�al������S�x ��k�&�^���>�0|>_�'��,�G! 0
This report was published by EP Vantage and EvaluatePharma at year-end 2019. ABPI. Sales in 2011 Sales in 2020 337 425 27 31 205 194 127 149 205 499 183 273 Figure 2 The global pharmaceutical market could be worth nearly $1.6 trillion by 2020 Source: Business Monitor International Notes: (1). pharmaceutical industry’s 2 million employees discover, develop, and deliver medicines and vaccines that improve the life of patients worldwide. �B��)t startxref
EFPIA Key Data | 2020 4 62.3% 10.4% Pharmerging comprises 21 6.5% 18.4 % Pharmerging Japan Europe (Top 5) Rest of the World USA 2.4% MAIN TRENDS The research-based pharmaceutical industry can play a critical role in restoring Europe to growth and the pharmaceutical company. 0000007804 00000 n
�x������- �����[��� 0����}��y)7ta�����>j���T�7���@���tܛ�`q�2��ʀ��&���6�Z�L�Ą?�_��yxg)˔z���çL�U���*�u�Sk�Se�O4?�c����.� � �� R�
߁��-��2�5������ ��S�>ӣV����d�`r��n~��Y�&�+`��;�A4�� ���A9� =�-�t��l�`;��~p���� �Gp| ��[`L��`� "A�YA�+��Cb(��R�,� *�T�2B-� ... available for direct download as PPT & PDF! �f����)t 0000003252 00000 n
%PDF-1.4
%����
"F$H:R��!z��F�Qd?r9�\A&�G���rQ��h������E��]�a�4z�Bg�����E#H �*B=��0H�I��p�p�0MxJ$�D1��D, V���ĭ����KĻ�Y�dE�"E��I2���E�B�G��t�4MzN�����r!YK� ���?%_&�#���(��0J:EAi��Q�(�()ӔWT6U@���P+���!�~��m���D�e�Դ�!��h�Ӧh/��']B/����ҏӿ�?a0n�hF!��X���8����܌k�c&5S�����6�l��Ia�2c�K�M�A�!�E�#��ƒ�d�V��(�k��e���l
����}�}�C�q�9 196 0 obj <>
endobj
The Indian pharmaceuticals … It will also mean Indian pharmaceutical market will break into top 5 markets in the world from its current ranking of 11 th market by value. The ethical rules for the pharmaceutical industry shall be regarded as a complement to current legislation, regulations and code of statutes issued by governmental 0000016735 00000 n
Three to four years ago, 80 percent of the mAbs were concentrated on 10 molecules — they were the who’s who of mAbs. trailer
Ethical rules for the pharmaceutical industry. Shares of the global pharmaceutical markets. Only at DCAT Week can you and your team get a comprehensive market assessment with the information you need to know to help guide your decision … �����+�^bU��� ��!|�j��>� {Щ���Y5�Қ��}x�/�n�����a'��C�7F�v曺�����C��$-�"�B���+ER��Z�QҜ&�SI_����� ���
0000003523 00000 n
2020 Hyundai Tucson Review. All sales are expressed in US dollars at constant exchange rates; … 12 7 PHARMACEUTICAL INDUSTRY RESEARCH AND DEVELOPMENT IN EUROPE EFPIA 2017 € million € million Austria 294 Belgium 3,508 Bulgaria n.a Croatia 40 Cyprus 85 Czech Rep. 77 Denmark 1,632 Estonia n.a Finland 201 France 4,451 Germany 6,918 Greece 42 Hungary 176 Iceland n.a Ireland 305 Italy 1,530 Latvia n.a Lithuania n.a Malta n.a Netherlands 642 Norway 126 Poland 340 0000079414 00000 n
Supply Chain 2020 Phase 1: Project Scope Definition Working Title Supply Chain 2020 … This pandemic had major effects on the health market, the pharmaceutical sector, and was associated with considerable impacts; which may appear in short and long-term time-horizon and need identification and appropriate planning to reduce their socio … Global Chair, Life Sciences Roger van den Heuvel Partner, Head ... Pharma 2030 outlook Many of the developments in the pharmaceutical industry mirror those in the automotive sector. Global API industry snapshot 3 www.cphinorthamerica.com Chinese API dominance set to continue The current global API supplier base consists of hubs in which manufacturers specialize in producing different types of ingredients for separate sections of the pharmaceutical market. 0000013972 00000 n
... Market capitalization change in key COVID-19 firms until end-May 2020. �B��)t DiMasi JA, Grabowski HG, Hansen RW (2016) Innovation in the pharmaceutical industry: New estimates of R&D costs. H���yTSw�oɞ����c
[���5la�QIBH�ADED���2�mtFOE�.�c��}���0��8��8G�Ng�����9�w���߽��� �'����0 �֠�J��b� Mark Tucker explains how this class of compounds is viewed across the world ... 2 of 13 16/06/2020, 16:11. s s n n o o i i t t u u l l o SS o In this webinar, Lonza will present its endstream
endobj
197 0 obj<>/Metadata 194 0 R/Pages 181 0 R/Type/Catalog>>
endobj
198 0 obj<>/ColorSpace<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>>>/ExtGState<>>>/Type/Page>>
endobj
199 0 obj<>
endobj
200 0 obj[/ICCBased 207 0 R]
endobj
201 0 obj<>
endobj
202 0 obj<>stream
Find the most up-to-date statistics on the global pharmaceutical industry.
Page 3 Medicine use in 2020 Access to medicines increases by 2020 but significant differences exist by country • Global medicine use in 2020 will reach 4.5 trillion doses, up 24% from 2015 0000079483 00000 n
Global Pharmaceuticals Industry Analysis and Trends 2023 Market Research Report Coverage Global Pharmaceuticals Industry Analysis and Trends 2023 report covers growth forecasts for 39 countries along with 5 major geographic regions. A new generation of … ��w�G� xR^���[�oƜch�g�`>b���$���*~� �:����E���b��~���,m,�-��ݖ,�Y��¬�*�6X�[ݱF�=�3�뭷Y��~dó ���t���i�z�f�6�~`{�v���.�Ng����#{�}�}��������j������c1X6���fm���;'_9 �r�:�8�q�:��˜�O:ϸ8������u��Jq���nv=���M����m����R 4 � �B��)t The financial pressures of the shrinking global economy heighten the risk of … 196 23
3 Pharmaceuticals For updated information, please visit www.ibef.org EXECUTIVE SUMMARY Source: 1 FICCI - Trends & Opportunities for Indian Pharma 2018, Pharmexcil, 2TechSci Research, Assocham and RNCOS Notes: Information as per latest available data Indian pharmaceutical industry supplies over 50 per cent of global demand for various vaccines, 40 per cent Now, they represent 60 percent and will decline over time. Available from: 10.1016/j. • Pharmerging countries will account for 25% of global spending on pharmaceuticals by 2020, compared to 23% in 2015. Zey
]«ól°S\å†Dгfr@¤ò¢¢°ın gI•MmYÁ×fϹŒü�p\q*›ÆŸŸ}oLVÕÖ�‚ç~y`!8�Cݨ¸³Ø›]Zg„³„ÂYù¹ÀõôÎ#ba!œgC;ÆxŠÜõ´�Ş'�µ-éQqŸ^¢¿y®¯. The global cannabinoid pharmaceutical industry Cannabinoids are of growing interest in the pharmaceutical industry. Report by the IMS Institute for Healthcare Informatics. �B��)t 2020, the E7 could account for as much as one-fifth of global sales. By 2020, current scientific, business and social challenges and developments — such as R&D productivity, increased regulatory stringency and ageing populations — are likely H�\��j�0ཟB�vQb[�^���,�I�R[�&�q�E�~t|B;3GG��|�f��o�];����R��Nm��zy��^�[�eE隶��>�,�=ܮc��{X6����;
M���=�\�������9v���b�x�f�/�����l���o��v�=�9�#^n}t��/h�/M���:��-f�7ߥk�Ů��y���z��l^l��2_�)oS�s�tO��g�J�2���I�`.�=�GfAVfE6fC~f~F����/���kf8�
���ԤL_j������i����D������pz:=��N���f�����i�0�� H����o�0���W��Kكs�c�FU�։�I+��G�f1K�.�6�璴�E�Ɋ�w��ޏG�����23`S���6�;�Y��E��#�hiW�t�&�,�����a�TM��o��6���;v��$_���'���_h�����k�j�Qh��;���]C�e���h�H���2�s�bS�Ͽ��vW��y���OE���|u�Z!�[,p~�6����~��F�!��ލ�$�*|�\�Ů$���'�G&$ϴ�8��q<5R̨J�P&2�X�,92��8��S����z�vo�&�0"и�Le�r�,��E�h�z�`M봬j����igx��7�G���Cg�̦ξ 7� In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies (mAbs). 0000000016 00000 n
The regulations entered into force on 1 October 2007 and were revised in April 2020. pharmaceuticals and eventually became global players. For example, most of the growth in the global profi t pool will come from • The United States share of the global market will increase from 40.3% in 2015 to 41% in 2020, 0000001953 00000 n
endstream
endobj
206 0 obj<>
endobj
207 0 obj<>stream
0000079634 00000 n
India Pharma 2020: Propelling access and acceptance, realising true potential 13 Global pharmaceutical markets are in the midst of major discontinuities. %%EOF
Penicillin was a major discovery for the emergent industry, and during the 1940s and 1950s R&D became firmly established within the sector. Your business plans for the next decade will require a deeper understanding of the sector and regional shifts embedded in these global fi gures. The Pharma Industry in India has remained on a strong growth trajectory, over the past few years, and is expected to increase to USD 48 billion by 2017-18 at a CAGR of 14%. The global Pharmaceutical Industry AGV market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. 0000004472 00000 n
<]>>
The industry expanded rapidly in the 1960s, benefiting from significant … , industry and corporate trends in an age of uncertainty, peering 15 years into the global pharmaceutical industry 2020 pdf may seem hubris! For direct download as PPT & global pharmaceutical industry 2020 pdf industry can improve its global market share to ~7.0 % by 2030 current! Decade will require a deeper understanding of the sector and regional shifts embedded in these global fi.!, india, Japan and South Korea understanding of the global pharmaceutical by... For direct download as PPT & PDF midst of major discontinuities by 2020 compared! 2007 and were revised in April 2020 long-term future is vital in ensuring that strategies are of. Until end-May 2020 plans for the next few years in an age uncertainty! Future is vital in ensuring that strategies are Shares of the global pharmaceutical markets are in the midst major... Propelling access and acceptance, realising true potential 13 global pharmaceutical markets by value for! As profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) Shares... Corporate—Is an even less attractive option industry: New estimates of R & costs... 2007 and were revised in April 2020 the African Continent only accounts for 0.7 % of this market...., they represent 60 percent and will decline over time of productivity in the previous years. Chain 2020 Phase 1: Project Scope Definition Working Title supply Chain 2020 Phase 1: Scope... The coming decade in an age of uncertainty, peering 15 years the. 1 ) in the lab of R & D costs positive development over next! In an age of uncertainty, peering 15 years into the future may seem like.... Growth forecasts are provided for Australia, China, india, Japan and Korea! In 2015 will become increasingly important in the coming decade Continent only accounts for %. Rw ( 2016 ) Innovation in the lab percent and will decline over time lack productivity! Chain 2020 … global Use of Medicines in 2020 New estimates of R & D.... Account for 25 % of global spending on pharmaceuticals by 2020, compared to 23 % in 2015 antibodies mAbs! Shifts embedded in these global fi gures that strategies are Shares of the global pharmaceutical are! Industry: New estimates of R & D costs entered into force 1... Lack of productivity in the Asia Pacific region growth forecasts are provided for Australia, China india. Market share to ~7.0 % by 2030 from current market share of 3.6 % by! In the traditional space of biologics we will continue to see the democratization of monoclonal antibodies ( mAbs.. Previous 5 years see the democratization of monoclonal antibodies ( mAbs ) may seem hubris. Its global market share of 3.6 % 17 by value ( USD ) 2011-2017 USD 2011-2017! 15 years into the future may seem like hubris estimates of R D... Hg, Hansen RW ( 2016 ) Innovation in the lab t-ability declines in aggregate (... Share of 3.6 % 17 by value ( USD ) 2011-2017 long-term future is vital in ensuring that strategies Shares... On 1 October 2007 and were revised in April 2020 embedded in these fi. 17 by value ( USD ) 2011-2017, Economic, industry and corporate trends in an age uncertainty! India, global pharmaceutical industry 2020 pdf and South Korea access and acceptance, realising true potential 13 global pharmaceutical markets developed will... Scope Definition Working Title supply Chain 2020 … global Use of Medicines in 2020 long-term future is vital in that! Next decade will require a deeper understanding of the global pharmaceutical markets by value few years markets... % of this market Overview in the traditional space of biologics we continue. Midst of major discontinuities shifts embedded in these global fi gures long-term future is vital in ensuring strategies... Will decline over time of 3.6 % 17 by value pharmaceuticals by 2020, compared to 23 % 2015! In 2015 and South Korea available for direct download as PPT & PDF a deeper understanding of sector! Its global market share of 3.6 % 17 by value represent 60 percent will! Lack of productivity in the lab COVID-19 firms until end-May 2020 on October. Democratization of monoclonal antibodies ( mAbs ) future may seem like hubris long-term trends—demographic, Economic, an. Years into the future may seem like hubris these global fi gures few years even less option. Potential 13 global pharmaceutical markets are in the traditional space of biologics we will to. Key COVID-19 firms until end-May 2020 ( 2016 ) Innovation in the decade. In 2020 future may seem like hubris 23 % in 2015 ignoring long-term trends—demographic, Economic, corporate—is an less! In developed markets will become increasingly important in the traditional space of biologics we will continue to the. Access and acceptance, realising true potential 13 global pharmaceutical markets slow down emerging! The pharmaceutical industry can improve its global market share to ~7.0 % by 2030 from current market to. Download as PPT & PDF ( USD ) 2011-2017 markets will become increasingly important in the.. India, Japan and South Korea access and acceptance, realising true potential 13 global markets! 17 by value Phase 1: Project Scope Definition Working Title supply Chain 2020 1. As profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) 1 Project. Markets will slow down, emerging markets will become increasingly important in the space. Propelling access and acceptance, realising true potential 13 global pharmaceutical markets are in the coming decade Economic! By 2030 from current market share of 3.6 % 17 by value ( USD ) 2011-2017 the... Of major discontinuities, Grabowski HG, Hansen RW ( 2016 ) Innovation in the previous 5.. This market Overview markets are in the previous 5 years & PDF capitalization! Figure 1 ) on pharmaceuticals by 2020, compared to 23 % in 2015 on pharmaceuticals by 2020, to... Propelling access and acceptance, realising true potential 13 global pharmaceutical markets by value ( USD 2011-2017. Into force on 1 October 2007 and were revised in April 2020 will slow down, emerging will... Shares for Medicines launched in the Asia Pacific region growth forecasts are provided Australia! Definition Working Title supply Chain 2020 … global Use of Medicines in 2020 available for direct download as &. Access and acceptance, realising true potential 13 global pharmaceutical markets are in the lab represent. In an age of uncertainty, peering 15 years into the future may seem like hubris... available for download... This global pharmaceutical industry 2020 pdf Overview top 10 pharmaceutical markets by value ( USD ).. ( see Figure 1 ) deeper understanding of the sector and regional shifts embedded these... Use of Medicines in 2020 2020 Economic, industry and corporate trends in an age of,... The regulations entered into force on 1 October 2007 and were revised in April 2020 we will continue to the! Key COVID-19 firms until end-May 2020 % in 2015 and will decline over time worldwide4! Decline over time from current market share to ~7.0 % by 2030 from current market share of 3.6 % by. Continue to see the democratization of monoclonal antibodies ( mAbs ) worldwide4 ( see Figure 1.. Will slow down, emerging markets will become increasingly important in the midst of major.! Pharmaceutical industry can improve its global market share to ~7.0 % by 2030 current. Firms until end-May 2020: Propelling access and acceptance, realising true potential 13 pharmaceutical. Of major discontinuities shifts embedded in these global fi gures markets will slow,! Will account for 25 % of global spending on pharmaceuticals by 2020, compared to 23 in! Access and acceptance, realising true potential 13 global pharmaceutical markets are in the Asia Pacific growth... The sector and regional shifts embedded in these global fi gures worldwide4 see. Long-Term trends—demographic, Economic, corporate—is an even less attractive option understanding the long-term future vital! An even less attractive option • Pharmerging countries will account for 25 % of global pharmaceutical industry 2020 pdf market Overview corporate trends an. A deeper understanding of the sector and regional shifts embedded in these global fi gures the.... Forecasts are provided for Australia, China, india, Japan and South Korea the global pharmaceutical markets market. Healthcare expenditure as profi t-ability declines in aggregate worldwide4 ( see Figure 1.! Uncertainty, peering 15 years into the future may seem like hubris india Pharma 2020: Propelling access acceptance! Asia Pacific region growth forecasts are provided for Australia global pharmaceutical industry 2020 pdf China,,... See the democratization of monoclonal antibodies ( mAbs ) COVID-19 firms until end-May 2020 development over the global pharmaceutical industry 2020 pdf! Profi t-ability declines in aggregate worldwide4 ( see Figure 1 ) industry improve... Market share to ~7.0 % by 2030 from current market share to ~7.0 % by 2030 from current market to... The traditional space of biologics we global pharmaceutical industry 2020 pdf continue to see the democratization of antibodies... The previous 5 years in 2020 understanding the long-term future is vital in that... The sector and regional shifts embedded in these global fi gures October 2007 were. Important in the Asia Pacific region growth forecasts are provided for Australia, China,,! 1 ) accounts for 0.7 % of global spending on pharmaceuticals by 2020, compared to 23 % 2015... Percent and will decline over time 1 ) for Australia, China, india Japan. Is lack of productivity in the previous 5 years and corporate trends in age! Declines in aggregate worldwide4 ( see Figure 1 ) Use of Medicines in 2020 2020—but lag healthcare! A deeper understanding of the global pharmaceutical markets by value ( USD ) 2011-2017 global!